Cargando…
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19
In late 2019, SARS-CoV-2 was detected in China and spread worldwide. In rare cases, children who were infected with COVID-19 may develop multisystem inflammatory syndrome (MIS-C), which could have higher mortality than COVID-19 itself. Therefore, diagnosis and management are critical for treatment....
Autores principales: | Long, Fangyuan, Zhu, Shiheng, Wang, Zeguang, Zhang, Shungeng, He, Jinlong, Ge, Xinbin, Ning, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853872/ https://www.ncbi.nlm.nih.gov/pubmed/36699562 http://dx.doi.org/10.2217/fvl-2022-0048 |
Ejemplares similares
-
Multisystem Inflammatory Syndrome in Children (MIS-C) — Recent Updates
por: Sood, Mangla, et al.
Publicado: (2020) -
Treatment of Multisystem Inflammatory Syndrome in Children
por: McArdle, Andrew J., et al.
Publicado: (2021) -
Multisystem inflammatory syndrome in children with COVID-19
por: Gottlieb, Michael, et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children
por: Tabaac, Sydney, et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children
por: Waseem, Muhammad, et al.
Publicado: (2022)